Agape ATP (NASDAQ:ATPC – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.08) EPS for the quarter, FiscalAI reports. Agape ATP had a negative net margin of 85.94% and a negative return on equity of 5.47%. The business had revenue of $0.00 million during the quarter.
Agape ATP Stock Down 3.1%
ATPC stock opened at $1.23 on Tuesday. The business has a fifty day moving average of $1.83 and a two-hundred day moving average of $2.51. The stock has a market cap of $1.23 million, a price-to-earnings ratio of -1.66 and a beta of 0.55. Agape ATP has a 52-week low of $1.15 and a 52-week high of $73.50.
Analysts Set New Price Targets
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Agape ATP in a report on Wednesday, August 19th. One investment analyst has rated the stock with a Sell rating. According to MarketBeat.com, Agape ATP has an average rating of “Sell”.
Get Our Latest Stock Analysis on Agape ATP
Agape ATP Company Profile
Agape ATP is a health and wellness company focused on personalized health management. Its offerings include nutritional and wellness products, health consultations and programs designed to support customers’ individual health goals. The company serves customers primarily in Malaysia and markets its products and services through direct-selling and related channels. Its offerings include the ATP Zeta Health Program, which combines wellness products with health-management services.
Read More
- Five stocks we like better than Agape ATP
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
